Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, recently announced that its parent company Elixinol Global (EXL) has raised A$50...
Elixinol Global Ltd
Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF) through its businesses has a global presence in the cannabis industry, including the use of CBD dietary supplements from cannabis, food and wellness products, as well as the cultivation and manufacture of medicated cannabis products.
Marijuana Infused Products
1d
5d
1m
6m
1y
Max
1d
5d
1m
6m
1y
Max
Elixinol Global Ltd News
04 Jun
Elixinol Participates In FDA's First CBD Hearing, Says Guidance, Clarity Will Benefit 'Good Players'
The Food and Drug Administration held its first-ever hearing on CBD Friday, and market leaders gave testimony on the state of the industry and what they hope it will look like going forward. One participant,...
03 Jun
Elixinol Issues a Statement Following the Public FDA Hearing in Washington, D.C. on Friday, May 31
DENVER, June 03, 2019 -- Elixinol issued the following statement regarding the public FDA hearing in Washington, D.C. on Friday, May 31. “We support the FDA’s intentions, we.
15 May
Elixinol Granted CBD Processor Research Partner Authorization by New York State
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has been officially granted a CBD Processor Research...
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have partnered with Cambrian Alliance (CA), one of...
Last week, Elixinol (OTC: ELLXF) snapped up a 25-percent stake in Altmeds, a company that makes CBD products for pets. Although some folks might dismiss the market for CBD-based pet products, it’s actually...
24 Apr
Elixinol to Acquire 25 Percent Stake in US-Based CBD Pet Products Brand Pet Releaf
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have purchased a 25 percent stake in Altmeds LLC, maker...
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces its latest product in partnership with Ken Brown, MD of KBMD Health,...
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has received U.S. Hemp Authority™ Certification. The...
12 Apr
Elixinol Global Limited strengthens Board with the addition of consumer retail specialist as Non-Executive
DENVER, April 12, 2019 -- Elixinol Global Limited (EXL or the Company) (ASX:EXL; OTCQX:ELLXF), a global company operating in the industrial hemp, dietary supplements and.
About Elixinol Global Ltd
Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF) through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, food and wellness products, as well as the cultivation and manufacture of medicinal cannabis products. Elixinol Global’s businesses include:
- Elixinol USA, which was founded in 2014, is a manufacturer and global distributor of industrial hemp-based dietary supplement and skin care products, with operations based out of Colorado, USA.
- Hemp Foods Australia, which was founded in 1999, is a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products.
- Nunyara was founded in 2014 to participate in the emerging Australian medicinal cannabis market and submitted license applications for cultivation and manufacture to the Office of Drug Control in early 2018. These applications are currently pending approval.
Participation in events
- CannaBiz Invest Asia
- 1 Dinso Rd, Khwaeng Wat Bowon Niwet, Khe...
$ 0.01
13.85%
Open:
0.01
High:
0.01
Low:
0.01
Share volume:
90.146 K
Total value:
156.855 K
Market cap:
105.341 M
Symbol:
ELLXF
Contact info
Phone:
+61 2 4044 4585
Address:
1 Macquarie Pl, Sydney NSW 2000, Australia
